Sopko B - Search Results

1

Structural requirements for inhibitors of cytochromes P450 2B: assessment of the enzyme interaction with diamondoids.

Hodek P, Bortek-Dohalská L, Sopko B, Sulc M, Smrcek S, Hudecek J, Janků J, Stiborová M. Hodek P, et al. Among authors: sopko b. J Enzyme Inhib Med Chem. 2005 Feb;20(1):25-33. doi: 10.1080/14756360400024324. J Enzyme Inhib Med Chem. 2005. PMID: 15895681

2

The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen.

Stiborová M, Sopko B, Hodek P, Frei E, Schmeiser HH, Hudecek J. Stiborová M, et al. Among authors: sopko b. Cancer Lett. 2005 Nov 18;229(2):193-204. doi: 10.1016/j.canlet.2005.06.038. Epub 2005 Aug 24. Cancer Lett. 2005. PMID: 16125300

3

Mapping of cytochrome P450 2B4 substrate binding sites by photolabile probe 3-azidiamantane: identification of putative substrate access regions.

Hodek P, Karabec M, Sulc M, Sopko B, Smrcek S, Martínek V, Hudecek J, Stiborová M. Hodek P, et al. Among authors: sopko b. Arch Biochem Biophys. 2007 Dec 1;468(1):82-91. doi: 10.1016/j.abb.2007.09.017. Epub 2007 Sep 29. Arch Biochem Biophys. 2007. PMID: 17961497

4

Evaluation of comparative cytochrome P450 2B4 model by photoaffinity labeling.

Hodek P, Sopko B, Antonovic L, Sulc M, Novák P, Strobel HW. Hodek P, et al. Among authors: sopko b. Gen Physiol Biophys. 2004 Dec;23(4):467-88. Gen Physiol Biophys. 2004. PMID: 15815081 Free article.

5

Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.

Stiborová M, Frei E, Sopko B, Wiessler M, Schmeiser HH. Stiborová M, et al. Among authors: sopko b. Carcinogenesis. 2002 Apr;23(4):617-25. doi: 10.1093/carcin/23.4.617. Carcinogenesis. 2002. PMID: 11960915

6

Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.

Stiborová M, Frei E, Sopko B, Sopková K, Marková V, Lanková M, Kumstýrová T, Wiessler M, Schmeiser HH. Stiborová M, et al. Among authors: sopko b. Carcinogenesis. 2003 Oct;24(10):1695-703. doi: 10.1093/carcin/bgg119. Epub 2003 Jul 17. Carcinogenesis. 2003. PMID: 12869422

7

Environmental pollutant and potent mutagen 3-nitrobenzanthrone forms DNA adducts after reduction by NAD(P)H:quinone oxidoreductase and conjugation by acetyltransferases and sulfotransferases in human hepatic cytosols.

Arlt VM, Stiborova M, Henderson CJ, Osborne MR, Bieler CA, Frei E, Martinek V, Sopko B, Wolf CR, Schmeiser HH, Phillips DH. Arlt VM, et al. Among authors: sopko b. Cancer Res. 2005 Apr 1;65(7):2644-52. doi: 10.1158/0008-5472.CAN-04-3544. Cancer Res. 2005. PMID: 15805261

8

Identification of Eukaryotic Translation Elongation Factor 1-α 1 Gamendazole-Binding Site for Binding of 3-Hydroxy-4(1 H)-quinolinones as Novel Ligands with Anticancer Activity.

Burglová K, Rylová G, Markos A, Prichystalova H, Soural M, Petracek M, Medvedikova M, Tejral G, Sopko B, Hradil P, Dzubak P, Hajduch M, Hlavac J. Burglová K, et al. Among authors: sopko b. J Med Chem. 2018 Apr 12;61(7):3027-3036. doi: 10.1021/acs.jmedchem.8b00078. Epub 2018 Mar 16. J Med Chem. 2018. PMID: 29498519

9

Molecular characterization of binding of calcium and carbohydrates by an early activation antigen of lymphocytes CD69.

Pavlícek J, Sopko B, Ettrich R, Kopecký V Jr, Baumruk V, Man P, Havlícek V, Vrbacký M, Martínková L, Kren V, Pospísil M, Bezouska K. Pavlícek J, et al. Among authors: sopko b. Biochemistry. 2003 Aug 12;42(31):9295-306. doi: 10.1021/bi027298l. Biochemistry. 2003. PMID: 12899616 Retracted.

10

Expression of Concern for "Identification of Eukaryotic Translation Elongation Factor 1-α 1 Gamendazole-Binding Site for Binding of 3-Hydroxy-4(1H)-quinolinones as Novel Ligands with Anticancer Activity".

Burglová K, Rylová G, Markos A, Prichystalova H, Soural M, Petracek M, Medvedikova M, Tejral G, Sopko B, Hradil P, Dzubak P, Hajduch M, Hlavac J. Burglová K, et al. Among authors: sopko b. J Med Chem. 2019 Sep 26;62(18):8664. doi: 10.1021/acs.jmedchem.9b01384. Epub 2019 Sep 9. J Med Chem. 2019. PMID: 31496240 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page